RECENT PRODUCT NEWS
The Academic Medical Center (AZP) in Paramaribo, Suriname, successfully studied an efficient method to collect COVID-19 antibody-containing plasma from recovered Covid-19 patients to treat critically ill patients.
Wassenburg Medical is a world leader in delivering excellent endoscope reprocessing products and solutions.
With the threat of COVID-19 pressing on, the winter months are a chilling prospect for hospitals and care homes alike.
An important breakthrough in COVID-19 treatment approaches has been described in a recent review, demonstrating for the first time the unique ability of D-xylose.
BECTON DICKINSON (BD) has received an order from the UK Government for 65 million needles and syringes to support the country’s COVID-19 vaccination efforts. The order is expected to be completed by mid-September.
The UK manufactured Face Coverings will be sold on Pennine’s e-commerce site, ARMA Health.
Patient trolley specialist Howard Wright is advising A&E departments how to make best use of the £300 million Government funding given to NHS trusts in England to increase capacity in preparation for a second wave of Covid-19.
Active Key is a leading designer and provider of hygienic, clinical & sealed industrial keyboards & mice for professional data input that are cleanable and sanitizable for use in the European market.
The UK manufactured Face Coverings and Sanitiser Stations will be sold on Pennine’s e-commerce site, ARMA Health.
West Midlands location has been allocated one of fifteen relocatable Canon Medical CT Scan Units as part of NHS England’s COVID-19 recovery plan to expand patient access to diagnostic imaging.
Virimask is the creation of respected, successful Medtech innovator Prof. Noam Gariely. His work over many years on personal protection from chemical and biological threats has resulted in a unique patent pending mask solution.
BAXTER has announced CE marking for the Evo IQ Syringe Infusion System. The company expects hospitals in the UK to be among the first to receive the new system, with additional countries to follow in a series of planned regulatory submissions.